Abstract
Monoclonal antibodies were raised against Daudi B-lymphoblastoid cell line membranes. An mAb (BAT) was selected for its ability to stimulate human and murine lymphocyte proliferation. BAT induced cytotoxicity in human and murine lymphocytes against natural killer cell-sensitive and -resistant tumor cell lines. A single intravenous administration of BAT to mice that had been inoculated with various murine tumors (e.g., B16 melanoma, 3LL carcinoma, and methylcholanthrene fibrosarcoma) resulted in striking antitumor effects as manifested by complete tumor regression and prolonged survival of the treated mice. BAT exhibited a diminished but significant antitumor effect in athymic nude mice, which are deficient in T lymphocytes, and in beige mice, which are deficient in NK cells. Furthermore, selective depletion of T or NK cells in mice reduced the response to the antitumor effect of BAT. These data indicate a dual role for T and NK cells in mediating the antitumor activity of BAT. We report here on the antitumor activity of BAT mAb on human tumor xenografts in mice. BAT demonstrated an antitumor effect in nude mice bearing human colon carcinoma (HT29) xenografts. It failed, however, to inhibit established lung metastases in severe ...Continue Reading
References
May 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·Z Razi-WolfH Reiser
Dec 1, 1991·The Journal of Experimental Medicine·A MorettaL Moretta
Dec 1, 1991·Cancer Metastasis Reviews·J C Buckner
May 1, 1991·Cancer Metastasis Reviews·P Brodt
Oct 28, 1988·Science·J D EllenhornJ A Bluestone
Mar 1, 1984·Proceedings of the National Academy of Sciences of the United States of America·S C MeuerE L Reinherz
Mar 19, 1981·Nature·O Stutman, M J Cuttito
Jul 1, 1994·British Journal of Haematology·I G Schmidt-WolfR S Negrin
Jun 1, 1995·Cancer Immunology, Immunotherapy : CII·B HardyA Novogrodsky
Jan 15, 1993·Science·S E Townsend, J P Allison
Feb 28, 1994·Journal of Immunological Methods·B ShpitzS Gallinger
Aug 27, 1994·Transplantation·K Takeda, G Dennert
Sep 1, 1986·Immunology Today·E A Clark, J A Ledbetter
Citations
Jan 29, 2011·Cancer Metastasis Reviews·Roch HouotRonald Levy
May 28, 2005·Vaccine·Britta Hardy, Annat Raiter
Sep 11, 1999·Immunology Letters·A RaiterB Hardy
Aug 1, 2000·Immunology Today·M J Glennie, P W Johnson
Jun 1, 2012·Clinical & Developmental Immunology·Ivetta DanyleskoArnon Nagler
Jul 25, 2014·Expert Opinion on Biological Therapy·Locke J Bryan, Leo I Gordon
Apr 20, 2005·Vaccine·Elena QuaglinoFederica Cavallo
Mar 10, 2015·Molecular Immunology·Abhisek SwaikaRichard W Joseph
May 13, 2010·Blood·Don M BensonMichael A Caligiuri
Oct 11, 2012·Immunotherapy·Ivetta DanyleskoArnon Nagler
Aug 27, 2005·Cancer Letters·Britta HardyYaron Niv
Apr 13, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Joshua BrodyRonald Levy
Nov 4, 2000·International Immunology·A RaiterB Hardy
Jun 12, 2014·Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners·Jing LuScott A Soefje
Apr 2, 2005·International Immunology·Britta HardyAnnat Raiter
Oct 4, 2007·The Journal of Immunology : Official Journal of the American Association of Immunologists·Leslie ElsnerRalf Dressel
Dec 5, 2008·Expert Review of Vaccines·Lina ZhaoDaiming Fan
Jul 18, 2019·Frontiers in Pharmacology·Jiqiao YangHubing Shi
Mar 14, 2020·Chemical Biology & Drug Design·Muhammad KalimJinbiao Zhan
May 17, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Raanan BergerArnon Nagler
Mar 19, 2021·Clinical and Experimental Immunology·Zhaoyun LiuRong Fu